about
Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop reportA new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malariaWhy did many more diamond miners than gold miners die in South Africa during the 1918 influenza pandemic?Deaths from bacterial pneumonia during 1918-19 influenza pandemic.Mortality risk factors for pandemic influenza on New Zealand troop ship, 1918.Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic.Host and environmental factors reducing mortality during the 1918-1919 influenza pandemic.Low but highly variable mortality among nurses and physicians during the influenza pandemic of 1918-1919.Determinants of mortality in naval units during the 1918-19 influenza pandemic.Epidemiological isolation causing variable mortality in Island populations during the 1918-1920 influenza pandemic.Differential mortality rates by ethnicity in 3 influenza pandemics over a century, New ZealandPathogenic responses among young adults during the 1918 influenza pandemic.Exceptionally high mortality rate of the 1918 influenza pandemic in the Brazilian naval fleet.Pacific islands which escaped the 1918-1919 influenza pandemic and their subsequent mortality experiences.Climate change and the resurgence of malaria in the East African highlandsClimate variability and malaria epidemics in the highlands of East AfricaMalaria and other vector-borne infection surveillance in the U.S. Department of Defense Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance program: review of 2009 accomplishments.Evaluation of the safety and tolerability of a short higher-dose primaquine regimen for presumptive anti-relapse therapy in healthy subjects.Temperature and malaria trends in highland East Africa.A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting.Population genetics of Plasmodium falciparum and Plasmodium vivax and asymptomatic malaria in Temotu Province, Solomon Islands.Malaria in Kenya's western highlands.Travel as a risk factor for uncomplicated Plasmodium falciparum malaria in the highlands of western Kenya.CYP450 phenotyping and metabolite identification of quinine by accurate mass UPLC-MS analysis: a possible metabolic link to blackwater fever.Reemergence of epidemic malaria in the highlands of western Kenya.Malaria's indirect contribution to all-cause mortality in the Andaman Islands during the colonial eraMeteorologic influences on Plasmodium falciparum malaria in the Highland Tea Estates of Kericho, Western Kenya.Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China.A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.Control and elimination of Plasmodium vivax.For severe malaria, artesunate is the answer.Island fever: the historical determinants of malaria in the Andaman Islands.Measles epidemics of variable lethality in the early 20th century.What really happened during the 1918 influenza pandemic? The importance of bacterial secondary infections.Single dose of azithromycin or three-day course of ciprofloxacin as therapy for epidemic dysentery in Kenya. Acute Dysentery Study Group.Extreme mortality after first introduction of measles virus to the polynesian island of Rotuma, 1911.Standby therapy to prevent Plasmodium falciparum infections?Open label randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in central Vietnam.Age-specific mortality during the 1918-19 influenza pandemic and possible relationship to the 1889-92 influenza pandemic.Acute eosinophilic pneumonia among US Military personnel deployed in or near Iraq.
P50
Q27024922-4ADB3949-E4E3-40DE-9467-A89A04E8C974Q28204425-E92CBC1F-154A-4616-80D9-7D3C2A4EBC08Q30353639-CA098260-78F7-4876-A04A-F54DF0007BE5Q30371219-72B2C1B8-4041-4A2B-B8F5-F5C459B8AD11Q30396882-F9141F16-88EC-44D5-912F-93F3083E1AC5Q30400578-F2E9FDB2-E603-47C4-B17C-86EB4D0EC958Q30400927-57BC7D4A-0C66-4B59-834B-C73FFAF1A46DQ30401674-460F3F5B-4FF9-4E51-BCC7-BBD84D67F706Q30407605-304DB758-A3F4-417D-82F0-F696E439EA83Q30411434-030525D3-A19D-4C0A-A972-FEB4C2D10063Q30411938-4D9CA756-4BDA-4585-BC43-02AFC5B56314Q30412566-D6041902-1776-43CC-AB83-F7289C4B2A85Q30413108-9CC2F4F1-2C1D-4E29-809D-C22CA2DE2E56Q30416462-2116A4BF-23CB-4A44-9AF0-4E88A46B34F3Q30675851-AE08C353-A7AE-432D-8109-BCE1E45F5DE8Q30981138-FDE1EC66-779F-4120-9AAF-3B42FB1FD6CCQ33841526-453F1547-3A57-429E-BA9B-7CB7DDC81689Q34010618-E446AD4F-C930-492B-BBFE-2F4E42177D51Q34026126-F9CA45C9-1FBC-42C3-A4C4-F7FD58E35493Q34149833-4B01015E-450B-4CD4-9BB3-21B297CE9E84Q34465321-50D39565-6704-4D53-8771-A0E69603A636Q35847394-53326E94-0D0B-4B5C-8BC2-8833E1A0BD11Q36463333-BF80E556-F86B-485B-8ABD-2FF82D3977DBQ36958153-34A36BFB-202D-41E6-B393-1BBA1C204049Q37092608-773542B6-7E24-42F6-83AC-DBAF275CE779Q37133873-5F266A4C-622D-4C1F-9C75-833100D7DB10Q37334482-08B21582-6BEF-4380-BA97-1154419AC2A1Q37348028-429B50E1-9A8C-4EC9-9142-004EAA68E1BFQ37617688-2EBCF4FC-D8F1-44C5-97BB-0C21BF060010Q39451447-13287E71-BC1D-496D-8CD3-E229340D2688Q39451454-4807CB01-03FB-463F-964F-29A587D7696AQ40380658-055D9784-C4F0-4D12-8C17-10F8A77888F8Q42238953-C9C6164A-751A-4F6E-8A5C-2F05E93085A5Q43689050-9062EE94-94E7-454D-935F-92F5E34F7A40Q44394202-55C998DB-3EF9-4B57-8D82-47CC3E4A6111Q44798871-1217CE08-7735-4E17-A8FF-2487B7E6BC86Q45218087-F898CCCB-8FEA-46EC-A301-91B13EB9311AQ46075114-8840AEE3-8A87-402F-B827-3EDE15E6DA9FQ47861550-537A7006-E033-4C7A-B697-9607B24C1087Q47875842-ED6CA469-CF15-4579-B320-60657AC08AC3
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
George Dennis Shanks
@ast
George Dennis Shanks
@en
George Dennis Shanks
@es
George Dennis Shanks
@nl
George Dennis Shanks
@sl
type
label
George Dennis Shanks
@ast
George Dennis Shanks
@en
George Dennis Shanks
@es
George Dennis Shanks
@nl
George Dennis Shanks
@sl
prefLabel
George Dennis Shanks
@ast
George Dennis Shanks
@en
George Dennis Shanks
@es
George Dennis Shanks
@nl
George Dennis Shanks
@sl
P1053
F-4056-2014
P106
P21
P31
P3829
P496
0000-0001-5763-8660